Joos Guy F, De Swert Katelijne O, Schelfhout Vanessa, Pauwels Romain A
Department of Respiratory Diseases, Ghent University Hospital, De Pintelaan 185, B 9000 Ghent, Belgium.
Ann N Y Acad Sci. 2003 May;992:218-30. doi: 10.1111/j.1749-6632.2003.tb03152.x.
The tachykinins substance P and neurokinin A are found within airway nerves and immune cells. They have various effects on the airways that can contribute to the changes observed in asthma and chronic obstructive pulmonary disease. Both tachykinin NK(1) and NK(2) receptors have been involved in the bronchoconstriction and the proinflammatory changes induced by substance P and neurokinin A. Tachykinin NK(1) and NK(2) receptor antagonists have activity in various animal models of allergic asthma and chronic bronchitis. It is suggested that dual NK(1)/NK(2) and triple NK(1)/NK(2)/NK(3) tachykinin receptor antagonists have potential in the treatment of obstructive airway diseases.
速激肽P物质和神经激肽A存在于气道神经和免疫细胞中。它们对气道有多种作用,可导致在哮喘和慢性阻塞性肺疾病中观察到的变化。速激肽NK(1)和NK(2)受体均参与了由P物质和神经激肽A诱导的支气管收缩和促炎变化。速激肽NK(1)和NK(2)受体拮抗剂在各种过敏性哮喘和慢性支气管炎动物模型中具有活性。有人提出,双重NK(1)/NK(2)和三重NK(1)/NK(2)/NK(3)速激肽受体拮抗剂在阻塞性气道疾病的治疗中具有潜力。